On The Fly
| ShowHide Related Items >><< - $185.99 /
+54.38 (+41.32%) - 04/13/21
- Zai Lab partner Novocure updates phase 3 Lunar trial in tumor fields in NSCLC
- 04/13/21
- Novocure: DMC recommends continuation of LUNAR trial
- 12/14/20
- Novocure announces BAG to add Optune combination to MiGeL
- 12/10/20
- Novocure enrolls 1st patient in global phase 3 TRIDENT trial
- $149.34 /
+10.05 (+7.22%) - 04/13/21
- Moderna says available mRNA-1273 data doesn't suggest association with CVST
- 04/07/21
- Moderna says NEJM study shows COVID antibody persistence out to 6 months
- $157.65 /
-3.935 (-2.44%) - 04/13/21
- White House says J&J pause will not significantly impact vaccination plan
- 04/13/21
- Johnson & Johnson to 'proactively delay' rollout of vaccine in Europe
- 04/13/21
- Moderna up 7% to $149.10 after CDC, FDA recommend pause in J&J vaccine use
- 04/13/21
- J&J drops 3% to $156.50 after CDC, FDA recommend pause in vaccine use
- 04/13/21
- Bally's to combine with Gamesys Group
- 03/24/21
- Bally's reports agreement in principle to buy Gamesys Group plc
- 04/06/21
- Crypto Council for Innovation launches with Square,Coinbase, Fidelity as members
- 03/22/21
- Coinbase ordered to pay $6.5M by CFTC for false, misleading reporting
- 12/17/20
- Coinbase announces confidential submission of draft registration statement
- 04/13/21
- Cardlytics to acquire Bridg for $350M in cash
- 03/09/21
- Cardlytics completes acquisition of Dosh
- 03/01/21
- Cardlytics to acquire Dosh for $275M in cash and stock
- 04/13/21
- Bally's falls -10.3%
- 04/13/21
- Bally's falls -11.5%
- 04/13/21
- Bally's falls -14.5%
- 04/13/21
- Gaming and Leisure Properties to acquire some of Bally's assets for $150M
- 04/13/21
- Boeing reports 196 gross commercial airplane orders in March
- 04/13/21
- Boeing announces 77 commercial airplane deliveries in Q1
- 04/09/21
- Boeing recommends 16 customers address potential issue for some 737 MAX jets
- 04/08/21
- Air Transport Services delivers third Boeing 767 freighter to Raya Airways
- 04/13/21
- AdaptHealth places co-CEO Luke McGee on unpaid leave
- 04/13/21
- AdaptHealth board: Denmark athorities formally charge co-CEO with tax fraud
- 01/04/21
- AdaptHealth falls 5% to $34.00 per share after equity offering
- 12/01/20
- AdaptHealth, AeroCare combination to operate under AdaptHealth name
- 04/13/21
- Grab/Altimeter Growth combo to have equity value of $39.6B on pro-forma basis
- 04/13/21
- Grab Holdings to go public via partnership with Altimeter Growth
- 03/11/21
- Altimeter Growth, Altimeter Growth 2 rally after WSJ report of Grab talks
- $157.65 /
-3.935 (-2.44%) - 04/13/21 Goldman Sachs
- J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
- 04/13/21 Morgan Stanley
- Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
- 04/13/21 JPMorgan
- Vaccine pause 'incremental negative' for J&J, says JPMorgan
- 04/13/21 Piper Sandler
- Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
- $149.34 /
+10.05 (+7.22%) - 04/07/21 Jefferies
- Catalent pact with Moderna removes potential overhang, says Jefferies
- 03/15/21 Piper Sandler
- Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study
- 04/13/21
- Fly Intel: Top five analyst initiations
- 04/13/21 MoffettNathanson
- Coinbase initiated with a Buy at MoffettNathanson
- 04/07/21 JMP Securities
- Coinbase report shows 'substantial business momentum,' says JMP Securities
- 03/03/21
- Fly Intel: Top five analyst initiations
- 04/09/21 Baird
- Baird says add to Boeing on any weakness due to 'tiny fix' needed for MAX jets
- 03/29/21 Goldman Sachs
- Boeing resuming 787 deliveries removes overhang, says Goldman Sachs
- 03/19/21 Susquehanna
- Boeing price target raised to $300 from $250 at Susquehanna
- 03/15/21 Morgan Stanley
- Aerospace sector upgraded to Attractive from Cautious at Morgan Stanley
- $185.99 /
+54.38 (+41.32%) - 04/13/21 Wells Fargo
- Novocure price target raised to $215 from $135 at Wells Fargo
- 04/13/21 Guggenheim
- Zai Lab price target raised to $250 from $165 at Guggenheim
- 04/13/21 Piper Sandler
- DMC review 'clear positive' for Novocure, says Piper Sandler
- 03/01/21 Mizuho
- Novocure price target raised to $175 from $150 at Mizuho
- 03/16/21 JPMorgan
- Cardlytics price target raised to $130 from $110 at JPMorgan
- 03/05/21 BofA
- Cardlytics upgraded to Neutral from Underperform at BofA
- 03/05/21 BofA
- Cardlytics upgraded to Neutral from Underperform at BofA
- 03/02/21 Truist
- Cardlytics price target raised to $150 from $90 at Truist
- 04/13/21 Canaccord
- Charges against McGee not related to AdaptHealth, says Canaccord
- 04/13/21 Stifel
- Stifel says AdaptHealth co-CEO news shouldn't have immediate impact on outlook
- 04/12/21 Baird
- AdaptHealth price target raised to $49 from $47 at Baird
- 03/18/21 Truist
- AdaptHealth initiated with a Buy at Truist amid home health market shift
- 04/08/21 KeyBanc
- Bally's price target raised to $70 from $65 at KeyBanc
- 03/29/21 Truist
- Early March casino data looks 'very positive,' says Truist
- 03/25/21 Stifel
- Bally's price target raised to $75 from $70 at Stifel
- 03/24/21 Jefferies
- Gamesys Group and Bally's an 'interesting combination,' says Jefferies
- 03/16/21 Jefferies
- Gamesys Group price target raised to 2,150 GBp from 1,930 GBp at Jefferies
- 03/10/21 Berenberg
- Gamesys Group price target raised to 1,700 GBp from 1,550 GBp at Berenberg
- 03/10/21 Deutsche Bank
- Gamesys Group price target raised to 1,580 GBp from 1,510 GBp at Deutsche Bank
- $185.99 /
+54.38 (+41.32%) - 02/25/21
- Novocure reports Q4 EPS 4c, consensus 12c
- 01/11/21
- Novocure sees FY20 revenue $494.4M, consensus $482.29M
- 01/11/21
- Novocure sees Q4 revenue $144M, consensus $133.26M
- 10/29/20
- Novocure reports Q3 EPS 9c, consensus 3c
- $149.34 /
+10.05 (+7.22%) - 02/25/21
- Moderna reports Q4 EPS (69c), consensus (35c)
- 02/24/21
- Notable companies reporting before tomorrow's open
- 10/29/20
- Moderna reports Q3 EPS (59c), consensus (43c)
- $157.65 /
-3.935 (-2.44%) - 01/26/21
- Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45
- 01/26/21
- Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82
- 01/25/21
- Notable companies reporting before tomorrow's open
- 04/06/21
- Coinbase gives Q2, FY21 expenses guidance
- 04/06/21
- Coinbase reports Q1 estimated total revenue of $1.8B
- 03/01/21
- Cardlytics sees FY21 revenue $250M-$275M, consensus $255.59M
- 03/01/21
- Cardlytics sees Q1 revenue $47M-$53M, consensus $50.07M
- 03/01/21
- Cardlytics reports Q4 adjusted EPS (5c), consensus (3c)
- 02/16/21
- Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet
- 04/13/21
- Bally's sees Q1 revenue $185M, consensus $156.45M
- 03/04/21
- Bally's reports Q4 adjusted EPS 39c, consensus (8c)
- 11/09/20
- Bally's Corporation changes name from Twin River Worldwide Holdings
- 01/27/21
- Boeing reports Q4 core EPS ($15.25), consensus ($1.80)
- 01/26/21
- Notable companies reporting before tomorrow's open
- 10/28/20
- Boeing reports Q3 core EPS ($1.39), consensus ($2.32)
- 03/04/21
- AdaptHealth raises FY21 revenue view to $2.18B-$2.35B from $2.05B-$2.2B
- 03/04/21
- AdaptHealth reports Q4 EPS (47c) with charge, consensus 17c
- 12/01/20
- AdaptHealth raises FY21 revenue view to $2.05B-$2.2B from $1.3B-$1.4B
- 11/04/20
- AdaptHealth sees FY21 revenue $1.3B-$1.4B, consensus $1.21B
|
On The Fly
| ShowHide Related Items >><< - 04/12/21
- AgroFresh Solutions appoints Clinton Lewis Jr. as CEO
- 04/12/21
- Myovant Sciences, Pfizer: First patient dosed in Phase 3 SERENE study
- $150.11 /
+10.82 (+7.77%) - 04/13/21
- Moderna says available mRNA-1273 data doesn't suggest association with CVST
- 04/07/21
- Moderna says NEJM study shows COVID antibody persistence out to 6 months
- $157.42 /
-4.165 (-2.58%) - 04/13/21
- White House says J&J pause will not significantly impact vaccination plan
- 04/13/21
- Johnson & Johnson to 'proactively delay' rollout of vaccine in Europe
- 04/13/21
- Moderna up 7% to $149.10 after CDC, FDA recommend pause in J&J vaccine use
- 04/13/21
- J&J drops 3% to $156.50 after CDC, FDA recommend pause in vaccine use
- $157.42 /
-4.165 (-2.58%) - 04/13/21 Goldman Sachs
- J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
- 04/13/21 Morgan Stanley
- Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
- 04/13/21 JPMorgan
- Vaccine pause 'incremental negative' for J&J, says JPMorgan
- 04/13/21 Piper Sandler
- Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
- $150.11 /
+10.82 (+7.77%) - 04/07/21 Jefferies
- Catalent pact with Moderna removes potential overhang, says Jefferies
- 03/15/21 Piper Sandler
- Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study
- 04/09/21
- Pfizer to host conference call
- 04/06/21 RBC Capital
- Pfizer transferred with a Sector Perform at RBC Capital
- 02/02/21
- Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19
- 02/02/21
- Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19
- 02/02/21
- Pfizer reports Q4 adjusted EPS 42c, consensus 48c
- 02/01/21
- Notable companies reporting before tomorrow's open
- $150.11 /
+10.82 (+7.77%) - 02/25/21
- Moderna reports Q4 EPS (69c), consensus (35c)
- 02/24/21
- Notable companies reporting before tomorrow's open
- 10/29/20
- Moderna reports Q3 EPS (59c), consensus (43c)
- $157.42 /
-4.165 (-2.58%) - 01/26/21
- Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45
- 01/26/21
- Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82
- 01/25/21
- Notable companies reporting before tomorrow's open
|
Options
|
Bullish option flow… Bullish option flow detected in Moderna with 28,974 calls trading, 4x expected, and implied vol increasing over 4 points to 64.56%. Apr-21 150 calls and Apr-21 160 calls are the most active options, with total volume in those strikes near 8,000 contracts. The Put/Call Ratio is 0.33. Earnings are expected on May 5th. ShowHide Related Items >><< - 04/13/21
- White House says J&J pause will not significantly impact vaccination plan
- 04/13/21
- Moderna says available mRNA-1273 data doesn't suggest association with CVST
- 04/13/21
- Moderna up 7% to $149.10 after CDC, FDA recommend pause in J&J vaccine use
- 04/07/21
- Moderna says NEJM study shows COVID antibody persistence out to 6 months
- 04/13/21 Morgan Stanley
- Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
- 04/13/21 Piper Sandler
- Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
- 04/07/21 Jefferies
- Catalent pact with Moderna removes potential overhang, says Jefferies
- 03/15/21 Piper Sandler
- Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study
- 02/25/21
- Moderna reports Q4 EPS (69c), consensus (35c)
- 02/24/21
- Notable companies reporting before tomorrow's open
- 10/29/20
- Moderna reports Q3 EPS (59c), consensus (43c)
|
Options
| ShowHide Related Items >><< - $721.88 /
+20.69 (+2.95%) - 04/09/21
- Tesla CEO offers 'congrats to NIO' on 100,000 vehicle milestone
- 04/02/21
- Tesla reports Q1 deliveries of 184,800, production of 180,338
- 03/25/21
- Evmo announces delivery of first fleet of Tesla vehicles
- 03/24/21
- Tesla now accepting bitcoin as form of payment for cars
- $618.75 /
+10.52 (+1.73%) - 04/12/21
- Nvidia announces eight new Ampere architecture GPUs
- 04/12/21
- Cloudera up 3% to $13.01 after announcing collaboration with Nvidia
- 04/12/21
- Cloudera collaborates with Nvidia to accelerate data analytics, AI in the cloud
- 04/12/21
- Nvidia unveils Nvidia Drive Atlan 'AI center on wheels'
- 04/08/21
- Hologic to acquire Mobidiag Oy for $795M, sees dilution
- 03/10/21
- Quidel slips, drags on peers as demand for testing 'softens significantly'
- 03/08/21
- Hologic, Gallup to create the Hologic Global Women's Health Index
- 03/01/21
- Hologic acquires Diagenode for $159M, sees accretion after FY22
- 02/25/21
- Etsy up 3% to $203.89 after earnings beat estimates
- 01/26/21
- Etsy up 10% in pre-market after Telsa CEO professes 'love' in tweet
- 11/25/20
- WWE names Karen Mullane as Controller & Chief Accounting Officer
- 11/04/20
- Etsy director sells 8K shares of common stock
- 03/23/21
- Beckman Coulter receives Emergency Use Authorization for antibody test
- 03/11/21
- Danaher not seeing decline in Covid testing business
- 03/02/21
- Director of Danaher Mitchell Rales purchases $1.4M in shares
- 01/13/21
- Danaher expects Q4 revenue up approx. 38.5% y-o-y, consensus $6.44B
- $721.88 /
+20.69 (+2.95%) - 07:58 Today Credit Suisse
- Credit Suisse ahead of consensus into Q1 EPS for Tesla
- 04/12/21
- Fly Intel: Top five analyst upgrades
- 04/12/21 Canaccord
- Canaccord upgrades Tesla with over $1,000 target on 'Apple-esque' ecosystem
- 04/12/21 Canaccord
- Tesla upgraded to Buy from Hold at Canaccord
- 04/05/21 Jefferies
- Hologic price target raised to $110 from $106 at Jefferies
- 02/22/21 BTIG
- Hologic price target raised to $91 from $84 at BTIG
- 01/28/21 Wells Fargo
- Hologic price target raised to $95 from $90 at Wells Fargo
- 12/08/20 Argus
- Hologic price target raised to $100 from $85 at Argus
- $618.75 /
+10.52 (+1.73%) - 08:56 Today Wells Fargo
- Nvidia price target raised to $715 from $625 at Wells Fargo
- 07:49 Today Cowen
- Nvidia price target raised to $675 from $665 at Cowen
- 07:12 Today Credit Suisse
- Nvidia price target raised to $700 from $620 at Credit Suisse
- 07:08 Today Deutsche Bank
- Nvidia price target raised to $575 from $560 at Deutsche Bank
- 04/08/21 Citi
- Citi opens 'positive catalyst watch' on Danaher, sees Q1 beat
- 04/07/21 Baird
- Danaher assumed with an Outperform at Baird
- 03/18/21 KeyBanc
- Thermo Fisher upgraded to Overweight at KeyBanc after Sartorius guidance
- 03/02/21 Barclays
- Danaher started at Overweight at Barclays on GE biopharma business potential
- 04/05/21 Evercore ISI
- Etsy initiated with an Outperform at Evercore ISI
- 03/29/21 Deutsche Bank
- Etsy price target raised to $239 from $162 at Deutsche Bank
- 03/02/21 Citi
- Etsy price target raised to $260 from $250 at Citi
- 02/26/21 Morgan Stanley
- Etsy price target raised to $123 from $93 at Morgan Stanley
- $721.88 /
+20.69 (+2.95%) - 01/27/21
- Tesla reports Q4 non-GAAP EPS 80c, consensus $1.01
- 01/27/21
- Notable companies reporting after market close
- 10/21/20
- Tesla reports Q3 non-GAAP EPS 76c, consensus 56c
- 10/21/20
- Notable companies reporting after market close
- $618.75 /
+10.52 (+1.73%) - 04/12/21
- Nvidia sees Q1 revenue tracking above $5.3B guide, consensus $5.32B
- 02/24/21
- Nvidia sees Q1 revenue $5.3B +/- 2%, consensus $4.51B
- 02/24/21
- Nvidia reports Q4 EPS $3.10, consensus $2.81
- 02/24/21
- Notable companies reporting after market close
- 01/27/21
- Hologic sees Q2 adjusted EPS $2.56-$2.68, consensus $2.02
- 01/27/21
- Hologic reports Q1 adjusted EPS $2.86, consensus $2.17
- 01/08/21
- Hologic reports preliminary Q1 revenue $1.61B, consensus $1.38B
- 02/25/21
- Etsy sees Q1 revenue $513M-$536M, consensus $380.45M
- 02/25/21
- Etsy reports Q4 EPS $1.08, consensus 59c
- 02/25/21
- Notable companies reporting after market close
- 10/28/20
- Etsy sees Q4 revenue year-over-year growth 70%-90%, consensus $436.19M
- 07:02 Today
- Danaher sees Q1 core revenue growth 'above high-end' of prior guidance
- 01/28/21
- Danaher reports Q4 non-GAAP EPS $2.08, consensus $1.87
- 01/27/21
- Notable companies reporting before tomorrow's open
|
Hot Stocks
|
The White House said in a… ShowHide Related Items >><< - 04/12/21
- AgroFresh Solutions appoints Clinton Lewis Jr. as CEO
- 04/12/21
- Myovant Sciences, Pfizer: First patient dosed in Phase 3 SERENE study
- 04/09/21
- Pfizer, BioNTech seek expansion of vaccine EUA to include 12-15 year olds
- 09:28 Today
- Moderna says available mRNA-1273 data doesn't suggest association with CVST
- 04/07/21
- Moderna says NEJM study shows COVID antibody persistence out to 6 months
- 04/07/21
- U.K. offers Pfizer, Moderna vaccine to those under 30 with risk conditions
- $157.25 /
-4.335 (-2.68%) - 09:25 Today
- Johnson & Johnson to 'proactively delay' rollout of vaccine in Europe
- 07:53 Today
- Moderna up 7% to $149.10 after CDC, FDA recommend pause in J&J vaccine use
- 07:15 Today
- J&J drops 3% to $156.50 after CDC, FDA recommend pause in vaccine use
- 07:14 Today
- FDA, CDC confirm recommendation to pause use of J&J COVID-19 vaccine
- $157.25 /
-4.335 (-2.68%) - 09:34 Today Goldman Sachs
- J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
- 09:33 Today Morgan Stanley
- Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
- 09:21 Today JPMorgan
- Vaccine pause 'incremental negative' for J&J, says JPMorgan
- 08:15 Today Piper Sandler
- Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
- 04/07/21 Jefferies
- Catalent pact with Moderna removes potential overhang, says Jefferies
- 03/15/21 Piper Sandler
- Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study
- 04/09/21
- Pfizer to host conference call
- 04/06/21 RBC Capital
- Pfizer transferred with a Sector Perform at RBC Capital
- 02/02/21
- Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19
- 02/02/21
- Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19
- 02/02/21
- Pfizer reports Q4 adjusted EPS 42c, consensus 48c
- 02/01/21
- Notable companies reporting before tomorrow's open
- 02/25/21
- Moderna reports Q4 EPS (69c), consensus (35c)
- 02/24/21
- Notable companies reporting before tomorrow's open
- 10/29/20
- Moderna reports Q3 EPS (59c), consensus (43c)
- $157.25 /
-4.335 (-2.68%) - 01/26/21
- Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45
- 01/26/21
- Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82
- 01/25/21
- Notable companies reporting before tomorrow's open
|